Table 1 Clinical, tumor and treatment characteristics

Number of patients

30

24

54

Age (mean ± SD; range)

71.29 ± 6.55; 55–88

73.20 ± 8.33; 50–90

72 ± 7.43; 55–90

PSA (mean ± SD)

0.76 ± 0.56

10.26 ± 9.89

4.99 ± 8.08

PRT

22

16

38

Brachytherapy

0

4

4

Radiotherapy on the prostatic region

12

8

20

Hormonal therapy

0

32

32

Chemotherapy

0

8

8

Other treatment

0

6

6

PSMA + 

16

22

38

PSMA-

14

2

16

Number of patients with lesions in prostatic region

8

7

15

Number of patients with lesions in pelvic lymph nodes

9

8

17